Johnson & Jоhnson brings this interlocutory appeal under 28 U.S.C.A. § 1292(b) (West Supp.1985), challenging the district court’s ruling that the payment and satisfaction of a judgment in a breach of contract action does not bar an action for fraud in the inducement of the contract arising under the same operative facts. In an earlier opinion,
McDonald v. Johnson & Johnson,
Facts
Stanley McDonald, Norman Hagfors, and Clayton Jensen (the plaintiffs) are the former owners of StimTech, a corporation that manufactures a painkilling device called TENS. 1 After acquiring 37.1% of StimTech’s stock in 1973, Johnson & Johnson purchased the remaining StimTech stock in 1974, making StimTech a wholly-owned subsidiary. The 1974 acquisition agreement provided, among other things, that Johnson & Johnson would pay plaintiffs a minimum of $1.3 million and a maximum of $7 million for the remaining StimTech stock based on the amount of StimTeeh’s profits during a five-year earnings period from 1975 to 1979.
On May 2, 1979, plaintiffs filed suit against Johnson & Johnson, alleging breach of contract, fraud, and violations of the Sherman and Clayton Acts. The plaintiffs alleged that Johnson & Johnson acquired StimTech in order to prevent the TENS devise from competing with Tylenol and оther painkilling drugs manufactured by Johnson & Johnson subsidiaries. To induce plaintiffs to sell StimTech, plaintiffs alleged, Johnson & Johnson made several
After an extended trial, the jury returned a verdict against Johnson & Johnson оn all counts except the Clayton Act violation. On appeal, we reversed the antitrust judgment for lack of standing, remanded the fraud claim, and affirmed the $5.7 million breach of contrаct award.
McDonald v. Johnson & Johnson,
Before retrial of the fraud claim, plaintiffs sought to collect on their contract judgment. Because the parties disagreed over whether plaintiffs’ collection of the contract judgment would extinguish plaintiffs’ alternative fraud claim, plaintiffs made a motion for clarification. After a hearing, the district court, Judge Miles W. Lord presiding, entered an ordеr stating that plaintiffs would not waive or extinguish their right to proceed on the fraud claim by collecting on the contract judgment. Plaintiffs then demanded and received payment of the $5.7 million сontract verdict. Johnson & Johnson thereafter moved for summary judgment on the fraud claim, asserting that collection of the contract judgment either constituted an election of remedies or precluded the fraud claim under the doctrine of res judicata. The district court, Judge Donald D. Alsop 2 presiding, denied Johnson & Johnson’s motion and certified the issue for appeal.
Discussion
Whether collection of plaintiffs’ breach of contract judgment рrecludes relitigation of plaintiffs’ fraud claim turns on whether the contract and fraud claims represent one cause of action with multiple theories of recovery or two distinct causes of action.
See Lawlor v. National Screen Service Corp.,
In our earlier opinion we observed that, although the plaintiffs рresented breach of contract and fraud claims, “any recovery in the new trial for fraud in terms of compensatory damages must be discounted by the breach of contract damage award.”
McDonald,
No policy inherent in res judicata principles is аt stake. Plaintiffs consolidated these various counts, including the antitrust claims, in the same case and tried them at the same time. It was only at Johnson & Johnson’s urging on appeal that we separated plaintiffs’ claims, affirming the breach of contract judgment and remanding the fraud claim. We find it fundamentally inconsistent for Johnson & Johnson to now urge that plaintiffs should be barred from pursuing their fraud claim merely because plaintiffs have proceeded in accordance with this court’s grant of Johnson & Johnson’s motion.
More significantly, Johnson & Johnson’s present argument is not supported by the law. As the partiеs recognize, res judicata
The Ninth Circuit explained thе underlying basis for this rule in Bankers Trust Co. v. Pacific Employers Insurance Co.:
Appellant allegedly had two separate causes of action; it had a right to sue to have the contract performed and a right to seek recovery for any fraud which induced the contract. Entirely different facts are essential to maintaining the two suits. The former required proof of the contract, appellant’s performanсe thereof and appellees’ failure to perform; the instant suit requires proof of fraud in the inducement of the contract.
Similarly, the fraud and contract claims of the plaintiffs in this case arose at different times and from different acts. Plaintiffs’ fraud claim arose when Johnson & Johnson first made the promises, without intending to honor them, that allegedly induced plaintiffs to enter into the StimTech purchase agreement; plaintiffs’ breach of contract claim arose only after Johnson & Johnson later failed to fulfill those promises. Although both the fraud and the contract claims look to Johnson & Johnson’s intent,
4
each claim focuses on John
We think it clear that plaintiffs’ fraud and contract claims arise from separate and distinct wrongful acts by Johnson & Johnson. We therefore affirm the district court’s holding that plaintiffs’ fraud and contract claims constitute separate causes of action and that plaintiffs’ collection of their contract judgment does not preclude litigation of their frаud claim.
Notes
. “TENS" is the abbreviation for transcutaneous electronic nerve stimulator. The device is used to treat pain by sending electric currents into the body through electrodes attached at the site of the pain.
. The case was assigned to Judge Alsop after Judge Lord disqualified himself.
. Johnson & Johnson’s contention that plaintiffs should be estopped from asserting that Johnson & Jоhnson's fraud antedated and induced the contract because plaintiffs never raised this claim below is wholly without merit. Judge Lord’s initial opinion makes it clear that plaintiffs' fraud claim was рredicated on their allegations that Johnson & Johnson made certain promises to the plaintiffs, which Johnson & Johnson never intended to fulfill, in an attempt to induce plaintiffs to sell StimTech to Johnson & Johnson.
See McDonald v. Johnson & Johnson,
. In our earlier opinion we noted that, because plaintiffs’ contract claim focused on that language in the StimTech agreement obligating the parties to act in good faith, a showing that Johnson & Johnson acted in bad faith was required to establish a breach of contract.
See McDonald,
